Delivery Order SPE2DB20D2104-SPE2DB25FMXCD
- Not listed
- The Defense Logistics Agency awarded a $1,117.20 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes management medication. This competitively awarded, firm fixed-price contract was executed on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract carries no set-aside designation and represents a discrete order fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a $2,717.61 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price contract, which is a child award under a larger indefinite delivery vehicle, represents a competitively awarded non-set-aside delivery order with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count packages) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,911.46 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on November 6, 2025, with an ultimate completion date of November 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Januvia 100 mg tablets in quantities of 90 units, with a contract ceiling value of $2,211.60. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,091.46 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Januvia 100 mg tablets (90-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 19, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,182.92 for 90 tablets of Januvia 100 mg on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- The Defense Logistics Agency awarded a delivery order valued at $1,584.99 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on December 18, 2025. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of December 19, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a $2,182.92 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication, on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price contract requires delivery to Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. No set-aside designation was applied to this award, demonstrating that AmerisourceBergen competed openly for the...
- The Defense Logistics Agency awarded a $1,105.16 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Januvia 100 mg tablets in a 90-count package. This firm fixed-price contract, which is set to be completed by July 31, 2025, represents a single delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where the company...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXCDDelivery Order
The Defense Logistics Agency awarded a $2,182.92 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order for pharmaceutical supply. The award was placed of performance at AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate office. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. The broader SPE2DX contract vehicle functions as a comprehensive global pharmaceutical support mechanism, enabling the company to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for Januvia, an antidiabetic medication, exemplifies the company's role in fulfilling routine pharmaceutical supply requirements under the DLA's pharmaceutical prime vendor program, which serves customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/1/25 |